Cargando…
Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study
BACKGROUND: EGFR‐mutant (EGFR‐M) and ALK‐positive (ALK‐P)are common in malignant pleural effusion (MPE) with metastatic non‐small‐cell lung cancer (NSCLC) (MPE‐NSCLC). The impact of thoracic tumor radiotherapy on survival in such patients remains unclear. We aimed to investigate whether thoracic tum...
Autores principales: | Li, Qingsong, Hu, Cheng, Su, Shengfa, Ma, Zhu, Geng, Yichao, Hu, Yinxiang, Jin, Haijie, Li, Huiqin, Lu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417183/ https://www.ncbi.nlm.nih.gov/pubmed/37288833 http://dx.doi.org/10.1002/cam4.6130 |
Ejemplares similares
-
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023) -
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment
por: Li, Qingsong, et al.
Publicado: (2022) -
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014) -
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
por: Li, Qingsong, et al.
Publicado: (2021) -
Survival benefit after radiotherapy for patients with malignant pleural mesothelioma: A propensity score‐matched study
por: Lian, Liyou, et al.
Publicado: (2023)